Dynavax Technologies (NASDAQ:DVAX) reported quarterly losses of $(0.77) per share which missed the analyst consensus estimate of $0.04 by 2025 percent. This is a 1000 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $68.20 million which missed the analyst consensus estimate of $70.58 million by 3.38 percent. This is a 34.28 percent increase over sales of $50.79 million the same period last year.